Correlation Between Inhibrx and Genscript Biotech
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Genscript Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Genscript Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Genscript Biotech, you can compare the effects of market volatilities on Inhibrx and Genscript Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Genscript Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Genscript Biotech.
Diversification Opportunities for Inhibrx and Genscript Biotech
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Inhibrx and Genscript is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Genscript Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genscript Biotech and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Genscript Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genscript Biotech has no effect on the direction of Inhibrx i.e., Inhibrx and Genscript Biotech go up and down completely randomly.
Pair Corralation between Inhibrx and Genscript Biotech
Given the investment horizon of 90 days Inhibrx is expected to under-perform the Genscript Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Inhibrx is 1.11 times less risky than Genscript Biotech. The stock trades about -0.09 of its potential returns per unit of risk. The Genscript Biotech is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 137.00 in Genscript Biotech on October 26, 2024 and sell it today you would lose (1.00) from holding Genscript Biotech or give up 0.73% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.24% |
| Values | Daily Returns |
Inhibrx vs. Genscript Biotech
Performance |
| Timeline |
| Inhibrx |
| Genscript Biotech |
Inhibrx and Genscript Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibrx and Genscript Biotech
The main advantage of trading using opposite Inhibrx and Genscript Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Genscript Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genscript Biotech will offset losses from the drop in Genscript Biotech's long position.| Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
| Genscript Biotech vs. Telix Pharmaceuticals Limited | Genscript Biotech vs. Keros Therapeutics | Genscript Biotech vs. Zentalis Pharmaceuticals Llc | Genscript Biotech vs. Innovent Biologics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |